Your browser doesn't support javascript.
loading
A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy.
Griffin, Patrick T; Komrokji, Rami S; De Castro, Carlos M; Rizzieri, David A; Melchert, Magda; List, Alan F; Lancet, Jeffrey E.
Afiliación
  • Griffin PT; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Komrokji RS; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • De Castro CM; Duke University Medical Center, Durham, North Carolina.
  • Rizzieri DA; Duke University Medical Center, Durham, North Carolina.
  • Melchert M; Florida Cancer Specialists, Tampa, Florida.
  • List AF; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Lancet JE; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Am J Hematol ; 90(9): 796-9, 2015 Sep.
Article en En | MEDLINE | ID: mdl-26089240
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Azacitidina / Leucemia Mieloide Aguda / Quimioterapia de Inducción / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Azacitidina / Leucemia Mieloide Aguda / Quimioterapia de Inducción / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2015 Tipo del documento: Article